ArticleInternational cancer conference journal2025

SMARCA4-deficient epithelioid sarcoma revealed by comprehensive genomic profiling, leading to a notable response by nivolumab treatment.

Mayumi Tokunaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.